9 hours ago, BBC, 6/1/2015
The Ebola outbreak in West Africa was first reported in March 2014, and has rapidly become the deadliest occurrence of the disease since its discovery in 1976.
In fact, the current epidemic sweeping across the region has now killed more than 11,130 people - five times more than all other known Ebola outbreaks combined.
Award-winning filmmaker Dan Edge has been investigating why the spread of Ebola was not curtailed sooner.
He was taken to the tree in Guinea thought to be the source of the latest outbreak.
Sentiment: Strong Sell
For those that want to make money on next weeks WWDC coverage where every day brings more positive news.
...they self admitted that they are openly engaging in illegal manipulation of the iron ore prices.....the sec refuses to consider any action against the criminals
In an oral presentation on Saturday, May 30, 2015 by Jae H. Park, M.D. of Memorial Sloan Kettering Cancer Center entitled, "Efficacy and safety of CD19-targeted 19-28z CAR modified T cells in adult patients with relapsed or refractory B-ALL", updated Phase I results in 39 adult patients treated with JCAR015 will be reported in this ongoing trial:
Complete remission (CR) was reported in 33/38 (87%) of evaluable patients and minimal residual disease (MRD) negative CR was reported in 26/32 (81%) of patients who achieved a CR.
Median overall survival (OS) for all efficacy evaluable patients (N=38) was 8.5 months, and the 6 month OS rate was 59% (95% CI: 39-74).
Durable responses were observed in patients with and without subsequent allogeneic stem cell transplant.
Severe cytokine release syndrome (CRS) was observed in 9/39 (23%) of patients. Severity of CRS correlated with disease burden and was generally reversible. Grade 3/4 neurotoxicity was observed in 11/39 (28%) of patients. Grade 5 toxicity was observed in 3/39 (8%) of patients, and assessed to be unrelated to JCAR015 treatment in one of these patients.
Gas prices rose four-cents over the past two weeks bringing the average price per gallon for regular to $2.84. Not as steep a climb as we've seen recently, prices went up nearly 35-cents per gallon between April 10th and May 15th.
Think you better read the anecdotal and dexcom information with an unbiased eye...
If Afrezza is performing idiosyncratically, that's an outlier.
And you may be a liar.
Sentiment: Strong Buy